ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Afinitor Suspension Approved For Rare Pediatric Brain Tumor

August 31, 2012

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

DCDDP Final Report; 3,557 Cancers, 90% By Mammography

July 9, 1982

ACS Updates Guidelines On Colorectal Screening.

February 2, 2001